Assignee
BRIGHTPATH BIOTHERAPEUTICS CO LTD
JP·0 granted patents·7 pending applications·0 citations·filing 2020–2023
Top patents by PatentIndex Score
7 records- 0162US2026085127A1Bispecific antibody to human tim-3 and human cd39, and use thereofBRIGHTPATH BIOTHERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 0256US2025215105A1Anti-cd39 antibodyBRIGHTPATH BIOTHERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 0354US2024391997A1Anti-tim-3 antigen antibody or antibody derivative, and use thereofBRIGHTPATH BIOTHERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0452US2023210967A1Improved peptide vaccineBRIGHTPATH BIOTHERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 0547US2023220104A1Anti-cd73 antibody and use thereofBRIGHTPATH BIOTHERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 0637US2022313803A1Novel neoantigens and cancer immunotherapy using sameBRIGHTPATH BIOTHERAPEUTICS CO LTD·Filed 2020·Application pending·0 cites
- 0729US2023321241A1Cancer peptide vaccine and method of preparing the sameBRIGHTPATH BIOTHERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BRIGHTPATH BIOTHERAPEUTICS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →